These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35882674)

  • 1. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
    AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
    Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
    Okamoto N; Higashino M; Yamamoto H; Sugano K
    Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
    Sakamoto A; Sugano K
    Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
    Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
    Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
    Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
    Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
    Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution Methods to Increasing Discriminatory Power of In Vitro Dissolution Testing for Ibuprofen Free Acid and Its Salts.
    Cristofoletti R; Dressman JB
    J Pharm Sci; 2017 Jan; 106(1):92-99. PubMed ID: 27397434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets.
    Ikuta S; Nakagawa H; Kai T; Sugano K
    Eur J Pharm Sci; 2023 Jan; 180():106326. PubMed ID: 36347443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.
    Sheng JJ; McNamara DP; Amidon GL
    Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen.
    Cámara-Martinez I; Blechar JA; Ruiz-Picazo A; Garcia-Arieta A; Calandria C; Merino-Sanjuan V; Langguth P; Gonzalez-Alvarez M; Bermejo M; Al-Gousous J; Gonzalez-Alvarez I
    Int J Pharm; 2022 Feb; 614():121415. PubMed ID: 34973409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
    Merchant HA; Goyanes A; Parashar N; Basit AW
    Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.
    Sudaki H; Fujimoto K; Wada K; Sugano K
    Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
    Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
    Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.